CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway

INTRODUCTION: Acute myeloid leukemia (AML), the hematological malignant tumor with high mortality, is still difficult to treat. CD40L is a type II transmembrane protein, which has been reported to have the potential to inhibit growth of some cancer cells. MATERIALS AND METHODS: In order to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zhongxin, Chen, Qi, Ren, Mingqiang, Tian, Zuguo, Gong, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476227/
https://www.ncbi.nlm.nih.gov/pubmed/31114244
http://dx.doi.org/10.2147/OTT.S175347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476227/
https://www.ncbi.nlm.nih.gov/pubmed/31114244
http://dx.doi.org/10.2147/OTT.S175347

Ejemplares similares